Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.4228
-0.0272 (-6.04%)
At close: Jun 6, 2025, 4:00 PM
0.4300
+0.0072 (1.70%)
After-hours: Jun 6, 2025, 7:26 PM EDT
Passage Bio Employees
Passage Bio had 60 employees as of December 31, 2024. The number of employees increased by 2 or 3.45% compared to the previous year.
Employees
60
Change (1Y)
2
Growth (1Y)
3.45%
Revenue / Employee
n/a
Profits / Employee
-$1,057,683
Market Cap
26.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
PASG News
- 24 days ago - Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 3 months ago - Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 3 months ago - Passage Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates - GlobeNewsWire
- 7 months ago - Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire
- 8 months ago - Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference - GlobeNewsWire
- 9 months ago - Passage Bio to Present at Chardan's 8th Annual Genetic Medicines Conference - GlobeNewsWire
- 9 months ago - Passage Bio Welcomes Tom Kassberg to Board of Directors - GlobeNewsWire